Bioinformatics analysis of multi-epitope peptide vaccines against Hepatitis C virus: a molecular docking studyarticle Published on 2023-11-142024-09-05 Journal: Journal of Genetic Engineering & Biotechnology [Category] update2024, [키워드] antigenicity CD4 CD8 Cellular responses docking scores HCV Humoral response Toxicity Vaccine development [DOI] 10.1186/s43141-023-00583-w PMC 바로가기 [Article Type] article
The future of cancer immunotherapy: DNA vaccines leading the wayReview Article Published on 2023-06-092024-09-05 Journal: Medical oncology (Northwood, London, England) [Category] update2024, [키워드] adjuvants cancer vaccines combination therapy DNA-based vaccines immune response Immunotherapy Vaccine development [DOI] 10.1007/s12032-023-02060-3 PMC 바로가기 [Article Type] Review Article
Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening저소득 및 중간소득 국가의 아동을 위한 시겔라 포함 조합 백신 개발의 도전과 기회: 전문가 회의 보고서Article Published on 2023-04-172024-08-22 Journal: Vaccine [Category] 세균성이질, [키워드] enteric diseases global health Immunization programme Policy Vaccine development [DOI] 10.1016/j.vaccine.2023.03.003
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccinationArticle Published on 2023-03-302024-09-05 Journal: Cell Reports [Category] update2024, [키워드] animal model Antibody responses coronavirus correlates of protection cross-protection FcR effector function pan-coronavirus vaccine sarbecovirus systems serology Vaccine development [DOI] 10.1016/j.celrep.2023.112326 PMC 바로가기 [Article Type] Article
Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19Review Published on 2023-01-012023-07-11 Journal: Pathology, research and practice [Category] COVID19(2023년), [키워드] COVID-19 Extracellular vesicles SARS-CoV-2 Therapeutics Vaccine development [DOI] 10.1016/j.prp.2022.154280 PMC 바로가기 [Article Type] Review
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review감염, 중증도, 입원 및 사망률 감소에 대한 COVID-19 백신의 효능 및 효과: 체계적인 검토Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] accelerated approved B.1.1.7 B.1.351 B.1.351 variants COVID-19 COVID-19 pandemic COVID-19 vaccine COVID-19 vaccines database disease transmission effective Effectiveness Efficacy effort growth Hospitalization identify inclusion criteria Infection infections Mortality Pfizer Pfizer/BioNTech populations reduced reducing regimen required Seven severity systematic literature search systematic review Vaccine Vaccine development Vaccines variants was performed [DOI] 10.1080/21645515.2022.2027160 PMC 바로가기 [Article Type] Article
Lambda Red Recombineering in Shigella flexneriarticle Published on 2022-12-312024-09-01 Journal: Methods in molecular biology (Clifton, N.J.) [Category] 세균성이질, [키워드] Congo red conjugation Shigella Vaccine development λ-Red recombination [Article Type] article
Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine Vaccine breakthrough Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
A statistical look at the COVID-19 vaccine development and vaccine policiesArticle Published on 2022-12-052023-07-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), [키워드] COVID-19 COVID-19 vaccine D Liability R& SARS-CoV-2 Vaccine development vaccine policy [DOI] 10.3389/fpubh.2022.1048062 PMC 바로가기
A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannanArticle Published on 2022-12-012022-11-15 Journal: International journal of biological macromolecules [Category] COVID19(2023년), SARS, 진단, [키워드] ACE2 adjuvant Antibody titer Antigen antigenicity Bacterial cause cellular immunity COVID-19 COVID-19 pandemic cytokine develop domain E. coli effective effective vaccine elicit elicited expected expressed feasibility humoral IFN-γ IL-10 IL-5 IMPROVE Interaction Ligand mannan neutralization neutralizing antibody organs peptide polysaccharide RBD RBD-specific IgG SARS-CoV-2 SARS-CoV-2 RBD SARS-CoV-2 spike protein SARS-CoV-2 vaccine sera severe respiratory disease Th2-type Toxicity Vaccine Vaccine development viral infection virus [DOI] 10.1016/j.ijbiomac.2022.09.180 PMC 바로가기